Researchers at Southeast University in China discovered that GLP-1 drugs like Ozempic produce unexpected mental health benefits beyond weight loss. The team found these medications reverse depression-like behavior in mice, with effects tied to gut microbiome changes rather than weight reduction itself.

The study revealed that blocking the GLP-1 receptor stopped weight loss but didn't prevent the antidepressant effect. This disconnect suggests separate biological pathways. Crucially, the drugs increased Lactobacillus delbrueckii populations in the gut, which produce endocannabinoids that reduce stress responses in brain regions like the amygdala.

Testing confirmed the mechanism: fecal transplants from treated mice improved mood in depressed recipients, and direct administration of L. delbrueckii produced similar benefits. This identifies the bacterium as a psychobiotic— a microbe that actively improves mental health. The findings align with broader research showing GLP-1 drugs reshape gut bacteria differently, with dulaglutide showing stronger microbiome effects than semaglutide.

These results suggest that live fermented foods containing L. delbrueckii—like yogurt, kefir, and cheese—might provide mood benefits similar to pharmaceutical GLP-1 drugs, but through natural dietary means rather than injections.